Therapeutic Group

Indication Dosage

Severe Acute Crohn's Disease, Maintenance Of Remission Of Crohn's Disease, Maintenance Of Remission Of Acute Ulcerative Colitis: 

• Adult: 2-2.5 Mg/kg Daily, Some Patients May Respond To Lower Doses 

Rheumatoid Arthritis, Severe Systemic Lupus Erythematosus And Other Connective Tissue Disorders, Polymyositis: 

• Adult: Initially Up To 2.5 Mg/kg Daily In Divided Doses, Adjusted According To Response, Rarely More Than 3 Mg/kg Daily; Maintenance 1-3 Mg/kg Daily, Discontinue If No Improvement Within 3 Months 

Autoimmune Conditions: 

• Adult: 1-3 Mg/kg Daily, Adjusted According To Response, Discontinue If No Improvement Within3 Months 

Suppression Of Transplant Rejection: 

• Adult: 1-2.5 Mg/kg Daily, Adjusted According To Response 

Severe Refractory Eczema: 

• Adult: 1-3 Mg/kg Daily (with Normal Or High Tpmt Activity), 0.5-1.5 Mg/kg Daily (with Intermediate Tpmt Activity) 

Generalized Myasthenia Gravis: 

• Adult: Initially 0.5-1 Mg/kg Daily, Then Increased To 2-2.5 Mg/kg Daily, Dose Is Increased Over 3-4 Weeks,

Content

Pregnancy

Consult with Doctor Or Caution Advised

Stability

Contra Indications

Precautions

Lactation

Side Effects